Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective …

BK Koo, J Kang, KW Park, TM Rhee, HM Yang… - The Lancet, 2021 - thelancet.com
Background Optimal antiplatelet monotherapy during the chronic maintenance period in
patients who undergo coronary stenting is unknown. We aimed to compare head to head the …

Safety and efficacy of everolimus-versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials

KW Park, SH Kang, MA Velders, DH Shin, S Hahn… - American heart …, 2013 - Elsevier
BACKGROUND: While EES have proven superior to paclitaxel-eluting stents, it remains
uncertain whether EES improve clinical outcomes compared to SES, which are the most …

[PDF][PDF] Adenylyl cyclase-associated protein 1 is a receptor for human resistin and mediates inflammatory actions of human monocytes

S Lee, HC Lee, YW Kwon, SE Lee, Y Cho, J Kim, S Lee… - Cell metabolism, 2014 - cell.com
Human resistin is a cytokine that induces low-grade inflammation by stimulating monocytes.
Resistin-mediated chronic inflammation can lead to obesity, atherosclerosis, and other …

Identification of a novel role of T cells in postnatal vasculogenesis: characterization of endothelial progenitor cell colonies

J Hur, HM Yang, CH Yoon, CS Lee, KW Park, JH Kim… - Circulation, 2007 - Am Heart Assoc
Background—The colony number of early endothelial progenitor cells (EPCs) has been
used as a quantitative indicator of the number of EPCs in the blood or as a biological marker …

[HTML][HTML] Prevalence of disability among the Chinese older population: a systematic review and meta-analysis

PP Zheng, ZL Guo, XJ Du, HM Yang… - International Journal of …, 2022 - mdpi.com
Background: Disability is an important problem in aging societies globally. However, the
research findings of the prevalence of disability have been inconsistent. This study aims to …

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE …

HS Kim, J Kang, D Hwang, JK Han, HM Yang, HJ Kang… - The Lancet, 2020 - thelancet.com
Summary Background A potent P2Y12 inhibitor-based dual antiplatelet therapy is
recommended for up to 1 year in patients with acute coronary syndrome receiving …

A novel noninvasive technology for treatment planning using virtual coronary stenting and computed tomography-derived computed fractional flow reserve

KH Kim, JH Doh, BK Koo, JK Min, A Erglis… - JACC: Cardiovascular …, 2014 - jacc.org
Objectives: This study sought to determine whether computational modeling can be used to
predict the functional outcome of coronary stenting by virtual stenting of ischemia-causing …

Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study

J Kang, KW Park, H Lee, D Hwang, HM Yang… - Circulation, 2023 - Am Heart Assoc
Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …

Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus …

KW Park, IH Chae, DS Lim, KR Han, HM Yang… - Journal of the American …, 2011 - jacc.org
Objectives: The goal of this study was to compare the angiographic outcomes of everolimus-
eluting stents (EES) and sirolimus-eluting stents (SES) in a head-to-head manner …

A multicentre cohort study of acute heart failure syndromes in Korea: rationale, design, and interim observations of the Korean Acute Heart Failure (KorAHF) registry

SE Lee, HJ Cho, HY Lee, HM Yang… - European journal of …, 2014 - Wiley Online Library
Aims The Korean Acute Heart Failure registry (KorAHF) aims to evaluate the clinical
characteristics, management, hospital course, and long‐term outcomes of patients …